Literature DB >> 19159074

Does Helicobacter pylori-induced inflammation of gastric mucosa determine the severity of symptoms in functional dyspepsia?

Ebru Turkkan1, Ihsan Uslan, Gursel Acarturk, Nevin Topak, Ahmet Kahraman, Fatma Husniye Dilek, Yusuf Akcan, Ozcan Karaman, Mehmet Colbay, Seref Yuksel.   

Abstract

BACKGROUND: Inflammation induces some structural and biochemical alterations and oxidative damage in gastric tissue. In this study, we aimed to investigate the relationship among the severity of symptoms, oxidative stress, and grading scales of Helicobacter pylori-induced gastric inflammation in functional dyspepsia.
METHODS: Thirty-five patients with functional dyspepsia were enrolled in the study. The severity of dyspepsia within the last 6 months was evaluated by Glasgow Dyspepsia Severity Score. In biopsy specimens of gastric mucosa, severity of gastritis was estimated by the revised Sydney Classification System, and oxidative stress parameters were studied.
RESULTS: Although there was no statistically significant relationship between symptom scores and degree of chronic inflammation, a tendency for symptoms to be more severe has been observed in low levels of gastritis. Levels of sulfhydryl groups were lower in subjects with high levels of chronic inflammation, and Helicobacter pylori intensity (P < 0.001 and P = 0.02, respectively). Levels of malondialdehyde were higher in subjects with high levels of chronic inflammation (P = 0.04). There was a statistically significant but a weak positive correlation between symptom scores and sulfhydryl levels (P < 0.001, r = 0.323).
CONCLUSIONS: In conclusion, there may be an inverse relation between severity of symptoms and level of Helicobacter pylori induced gastric inflammation or oxidative stress in patients with functional dyspepsia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19159074     DOI: 10.1007/s00535-008-2271-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  37 in total

1.  The glutathione instability of drug-sensitive red cells; a new method for the in vitro detection of drug sensitivity.

Authors:  E BEUTLER
Journal:  J Lab Clin Med       Date:  1957-01

2.  Reproducibility of gastric myoelectrical activity and the water load test in patients with dysmotility-like dyspepsia symptoms and in control subjects.

Authors:  K L Koch; S P Hong; L Xu
Journal:  J Clin Gastroenterol       Date:  2000-09       Impact factor: 3.062

3.  Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy.

Authors:  K Bodger; J I Wyatt; R V Heatley
Journal:  Helicobacter       Date:  2001-09       Impact factor: 5.753

4.  Abnormalities of the electrogastrogram in functional gastrointestinal disorders.

Authors:  A Leahy; K Besherdas; C Clayman; I Mason; O Epstein
Journal:  Am J Gastroenterol       Date:  1999-04       Impact factor: 10.864

5.  Gastrin (G) cells and somatostatin (D) cells in patients with dyspeptic symptoms: Helicobacter pylori associated and non-associated gastritis.

Authors:  Y Liu; G D C Vosmaer; G N J Tytgat; S-D Xiao; F J W Ten Kate
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

6.  Reactive oxygen species activity, mucosal lipoperoxidation and glutathione in Helicobacter pylori-infected gastric mucosa.

Authors:  H K Jung; K E Lee; S H Chu; S Y Yi
Journal:  J Gastroenterol Hepatol       Date:  2001-12       Impact factor: 4.029

7.  Symptom score does not correlate with gastritis grade and Helicobacter pylori infection in non ulcer dyspepsia.

Authors:  A Joshi; S D Gupta; V Ahuja; M P Sharma
Journal:  Trop Gastroenterol       Date:  2001 Oct-Dec

8.  Long term follow up of patients treated for Helicobacter pylori infection.

Authors:  R Mera; E T H Fontham; L E Bravo; J C Bravo; M B Piazuelo; M C Camargo; P Correa
Journal:  Gut       Date:  2005-06-28       Impact factor: 23.059

9.  Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.

Authors:  N J Talley; N Vakil; E D Ballard; M B Fennerty
Journal:  N Engl J Med       Date:  1999-10-07       Impact factor: 91.245

10.  Persisting chronic gastritis and elevated Helicobacter pylori antibodies after successful eradication therapy.

Authors:  Lea Veijola; Aino Oksanen; Auli Linnala; Pentti Sipponen; Hilpi Rautelin
Journal:  Helicobacter       Date:  2007-12       Impact factor: 5.753

View more
  11 in total

1.  Symptom-based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia.

Authors:  Ling Lan; Jing Yu; Yu-Long Chen; Ya-Li Zhong; Hao Zhang; Chang-He Jia; Yuan Yuan; Bo-Wei Liu
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

Review 2.  Functional Dyspepsia: Diagnostic and Therapeutic Approaches.

Authors:  Gregory S Sayuk; C Prakash Gyawali
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546

3.  What is the difference between Helicobacter pylori-associated dyspepsia and functional dyspepsia?

Authors:  Hidekazu Suzuki; Juntaro Matsuzaki; Toshifumi Hibi
Journal:  J Neurogastroenterol Motil       Date:  2011-04-27       Impact factor: 4.924

4.  Should we still subcategorize helicobacter pylori-associated dyspepsia as functional disease?

Authors:  Kentaro Sugano
Journal:  J Neurogastroenterol Motil       Date:  2011-10-31       Impact factor: 4.924

5.  Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria.

Authors:  Yu-Jen Fang; Jyh-Ming Liou; Chieh-Chang Chen; Ji-Yuh Lee; Yao-Chun Hsu; Mei-Jyh Chen; Ping-Huei Tseng; Chien-Chuan Chen; Chi-Yang Chang; Tsung-Hua Yang; Wen-Hsiung Chang; Jeng-Yi Wu; Hsiu-Po Wang; Jiing-Chyuan Luo; Jaw-Town Lin; Chia-Tung Shun; Ming-Shiang Wu
Journal:  Gut       Date:  2014-11-18       Impact factor: 23.059

Review 6.  The Role of H. pylori CagA in Regulating Hormones of Functional Dyspepsia Patients.

Authors:  Wang-Ping Meng; Zhong-Qiong Wang; Jia-Qi Deng; Yi Liu; Ming-Ming Deng; Mu-Han Lü
Journal:  Gastroenterol Res Pract       Date:  2016-10-20       Impact factor: 2.260

7.  Weikangning therapy in functional dyspepsia and the protective role of Nrf2.

Authors:  Yujuan Chang; Wei Wei; Li Tong; Yanjun Liu; Aimin Zhou; Jiande Chen; Ruhan Wei; Ping Zhang; Xiaolan Su
Journal:  Exp Ther Med       Date:  2017-08-07       Impact factor: 2.447

8.  Neutrophil-activating Protein Polymorphism of Helicobacter pylori Determines the Host Risk of Dyspepsia.

Authors:  Juntaro Matsuzaki; Hitoshi Tsugawa; Yuki Kashiwazaki; Hideki Mori; Yuta Yamamoto; Hisako Kameyama; Tatsuhiro Masaoka; Takanori Kanai; Hidekazu Suzuki
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-05-18

9.  Comparison of clinical symptoms after Helicobacter pylori eradication in functional dyspepsia patients based on endoscopic view of antral gastropathy.

Authors:  S Azadbakht; S Azadbakht; A Esmaili; P Rahmani
Journal:  New Microbes New Infect       Date:  2020-11-09

10.  Effect of Helicobacter pylori Eradication on Functional Dyspepsia.

Authors:  Sung Eun Kim; Young Soo Park; Nayoung Kim; Min Soo Kim; Hyun Jin Jo; Cheol Min Shin; Sang Hyub Lee; Jin-Hyeok Hwang; Jin-Wook Kim; Sook-Hyang Jeong; Dong Ho Lee; Hyun Chae Jung
Journal:  J Neurogastroenterol Motil       Date:  2013-04-16       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.